Intensive ketamine use for multiple years: A case report

American Journal on Addictions

Volumn 24, Issue 1, 2015, Pages 7-9

  Liu, James X ^a   Zerbo, Erin ^b   Ross, Stephen ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; CITALOPRAM; COCAINE; GABAPENTIN; HALOPERIDOL; KETAMINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; METHAMPHETAMINE; OLANZAPINE; PAROXETINE; RISPERIDONE; TRAZODONE; VALPROIC ACID; ANTIDEPRESSANT AGENT;

ADULT; ALCOHOL BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; CASE REPORT; DEPRESSION; DRUG DOSE TITRATION; ELECTROCONVULSIVE THERAPY; EVENING DOSAGE; HUMAN; HYPOMANIA; MALE; MEMORY DISORDER; MENTAL HEALTH CARE; MOOD; PSYCHOTHERAPY; SUBSTANCE ABUSE; SUICIDAL IDEATION; WITHDRAWAL SYNDROME; ADDICTION; COMPLICATION; PSYCHOLOGY; SELF MEDICATION; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

ADULT; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ADDICTIVE; BIPOLAR DISORDER; HUMANS; KETAMINE; MALE; SELF MEDICATION; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 84926035403     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12153     Document Type: Article

References (10)

1. Curran HV, Monaghan L,. 2001. In and out of the K-hole: A comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction. 96: 749-760.
2. Diazgranados N, Ibrahim L, Brutsche N, et al. 2010. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 67: 793-802.
3. Larkin GL, Beautrais AL,. 2011. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharm. 14: 1127-1131.
4. Morgan CJ, Muetzelfeldt L, Curran HV,. 2009. Ketamine use, cognition and psychological wellbeing: A comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction. 104: 77-87.
5. Critchlow DG,. 2006. A case of ketamine dependence with discontinuation symptoms. Addiction. 101: 1212-1213.
6. Kruptisky EM, Grinenko AY,. 1997. Ketamine psychedelic therapy (KPT): A review of the results of ten years of research. J Psychoactive Drugs. 29: 165-183.
7. Krupitsky E, Kolp E,. 2007. Ketamine psychedelic psychotherapy. In:, Winkelman MJ, Roberts TB, eds. Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. Westport, CT: Greenwood Publishing Group, Inc. pp 67-85.
8. Ross S,. 2008. Ketamine and addiction. Primary Psychiatry. 15: 61-69.
9. New York State Psychiatric Institute; National Institute on Drug Abuse. The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence. In: ClinicalTrials.gov [Internet]. New York (NY): National Library of Medicine (US). 2012- [cited 2014 May 10]. Available from: http://clinicaltrials.gov/ct2/show/NCT01535937 NLM Identifier: NCT01535937.
10. Phelps LE, Brutsche N, Moral JR, et al. 2009. Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry. 65: 181-184.